Showing results (51-60 of 216) with videos related to
Sort By:
Pageof 22
Crohn'S & Colitis 360|February 13, 2023
Serum Ustekinumab Concentrations Are Associated With Remission in Crohn's Disease Defined by a Serum-Based Endoscopic Healing IndexMargaret Walshe, Krzysztof Borowski, Robert Battat, et al.Human Immunology|April 26, 2011
Replication of genetic variation in the MYO9B gene in Crohn's diseaseVictorien M Wolters, Wei Xu, Xingqiu Zhao, et al.Journal of Crohn'S & Colitis|January 9, 2022
Combined Histo-endoscopic Remission but not Endoscopic Healing Alone in Ulcerative Colitis is Associated with a Mucosal Transcriptional Profile Resembling Healthy MucosaCristian Hernández-Rocha, Shadi Nayeri, Williams Turpin, et al.Inflammatory Bowel Diseases|January 26, 2012
Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's diseaseTravis B Murdoch, Wei Xu, Joanne M Stempak, et al.Journal of the Canadian Association of Gastroenterology|April 25, 2020
Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing EffectivenessPetros Zezos, Boyko Kabakchiev, Adam V Weizman, et al.Human Pathology|April 12, 2016
Intraepithelial lymphocytosis is a frequent finding in biopsies from ileal pouch-anal anastomosesDavid F Schaeffer, Joanna C Walsh, Andrea D Tyler, et al.Inflammatory Bowel Diseases|May 25, 2013
Serum antibodies associated with complex inflammatory bowel diseaseAbdul A Elkadri, Joanne M Stempak, Thomas D Walters, et al.Journal of Crohn'S & Colitis|October 30, 2015
IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease PatientsDavid Kevans, Mark S Silverberg, Krzysztof Borowski, et al.Journal of Crohn'S & Colitis|April 29, 2017
Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's DiseaseEran Zittan, Boyko Kabakchiev, Orlaith B Kelly, et al.Journal of Gastroenterology and Hepatology|May 21, 2021
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysisNeeraj Narula, Emily C L Wong, Raed AlRamdan, et al.Pageof 22